POSTERIOR SUB-TENON'S Avastin
Phase 4
Withdrawn
- Conditions
- Diffuse Diabetic Macular Edema
- Registration Number
- NCT00567372
- Lead Sponsor
- Asociación para Evitar la Ceguera en México
- Brief Summary
Posterior sub-tenon's injection of bevacizumab decreased diffuse diabetic macular edema
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- WITHDRAWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Patients with diffuse diabetic macular edema non-proliferative diabetic retinopathy Maculat thickness ≥250 μ BCVA ≥ 20/400 Without any treatment
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method macular volume baseline, 3,6 and 12 weeks
- Secondary Outcome Measures
Name Time Method macular thickness baseline,3,6 and 12 weeks best corrected visual acuity baseline, 3,6 and 12 weeks
Trial Locations
- Locations (1)
Asociación para Evitar la Ceguera en Mexico
🇲🇽Mexico DF, DF, Mexico